Gold( i )–BODIPY–imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Dalton Transactions Année : 2017

Gold( i )–BODIPY–imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents

Résumé

Two new gold(I)–BODIPY–imidazole based trackable therapeutic bimetallic complexes have been synthesized and fully characterized. They display strong antiproliferative properties on several types of cancers including colon, breast, and prostate and one of them presents a significant anti-inflammatory effect. Additionally, the two compounds could be visualised in vitro by confocal microscopy in the submicromolar range.

Domaines

Chimie Cancer
Fichier non déposé

Dates et versions

hal-01563252 , version 1 (17-07-2017)

Identifiants

Citer

Audrey Trommenschlager, Florian Chotard, Benoît Bertrand, Souheila Amor, Lucile Dondaine, et al.. Gold( i )–BODIPY–imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents. Dalton Transactions, 2017, 46 (25), pp.8051 - 8056. ⟨10.1039/C7DT01377A⟩. ⟨hal-01563252⟩
81 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More